Ogg1 regulates context-dependent glial states in Alzheimer's disease
Andreas AbentungiD, Teri Sakshaug, Paulina Schnur, Milena Egiazarian, Catarina Damião, Karoline Aakre, Tobias Obermann, Mirta Sousa, Nicolas KunathiD, Magnar BjøråsiD, Katja ScheffleriD
Abstract
Oxidative DNA damage is an early hallmark of Alzheimer's disease (AD), but whether Ogg1, a key enzyme in oxidative DNA repair, contributes to disease pathogenesis remains unclear. Here, we show that Ogg1 exerts opposing effects under physiological and disease conditions. Ogg1 deficiency impaired memory and induced glial transcriptional alterations under physiological conditions, whereas in APP/PS1 mice it improved memory, reduced amyloid burden and attenuated AD-associated glial remodeling. These effects occurred without changes in global 8-oxo-dG levels and were accompanied by changes in chromatin accessibility and gene expression, supporting a non-canonical role for Ogg1 in transcriptional regulation. Single-nucleus transcriptomics revealed strong transcriptional responses to Ogg1 deficiency across all major glial cell types and showed that Ogg1-dependent glial transcriptional programs are strongly conserved in human AD. These findings identify Ogg1 as a context-dependent regulator of glial cell states and reveal an unexpected role in AD-associated glial remodeling.
02 /Specification & Classification
Click any tag to browse matching papersReproducibility ledger
Nobody has reported trying to reproduce this paper yet. Did you replicate an experiment or run the code? Your report saves the next lab a week.
Sign in to file a reproducibility report.
Related papers
- Non-linear microglial, inflammatory and oligodendrocyte dynamics across stages of Alzheimer's disease
Aurélien M. Badina, Kelly Ceyzériat, … Benjamin B. Tournier·Neurobiology of DiseasePeer-reviewed·May 8, 2025
- Early oligodendrocyte dysfunction signature in Alzheimer's disease: Insights from DNA methylomics and transcriptomics
Katherine Fodder, Hannah M. G. Smith, … Conceição Bettencourt·Molecular PsychiatryPeer-reviewed·Jun 18, 2026
- Fus depleted oligodendrocytes reduce neuronal damage and attenuate AD progression in the AppNL-G-F mouse
Te-Hsuan Tung, Sudhagar Babu, … Franca Cambi·bioRxiv·Nov 24, 2025
- Riluzole shifts glial responses to protect synapses and memory in Aβ oligomer-treated rats
Min-Kaung Wint-Mon, Hiroyuki Kida, … Dai Mitsushima·bioRxiv·Jan 30, 2026
- Acute increase of protein O-GlcNAcylation in mice leads to transcriptome changes in the brain opposite to what is observed in Alzheimer Disease
Margaret Bell, Mariame Selma Kane, … Jianhua Zhang·bioRxiv·Sep 19, 2024
- BT-11 repurposing potential for Alzheimer's disease and insights into its mode of actions
Emily M. Birnbaum, Lei Xie, … Maria E. Figueiredo-Pereira·bioRxiv·Oct 29, 2024